Skip to content

Nuevo Amanecer: Promoting the Psychosocial Health of Latinas

Nuevo Amanecer: Promoting the Psychosocial Health of Latinas

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01383174
Enrollment
151
Registered
2011-06-28
Start date
2011-02-28
Completion date
2014-05-31
Last updated
2019-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms, Psychology, Social

Keywords

Breast cancer, Latinas, Peer support counselor, Spanish speaking, Community based

Brief summary

The purpose of this study is to test whether a new program Nuevo Amanecer (A New Dawn), improves the quality of life of Latinas diagnosed with breast cancer. Trained Latina counselors who have had breast cancer provide support to recently diagnosed women. The investigators call these counselors peer support counselors.

Detailed description

This study will assess the effectiveness of a cognitive-behavioral stress management (CBSM) intervention for newly diagnosed Latina breast cancer patients. In our prior work, the investigators established the appropriate content of the intervention, the need for early intervention, and the value of culturally competent peer support. In this study the investigators will adapt an evidence-based CBSM intervention designed to meet these needs. This study will use a randomized controlled trial (RCT) design with a wait-listed usual care control group to adapt the intervention and test its effectiveness in improving breast cancer specific quality-of-life, and decreasing anxiety and breast cancer specific distress. The new, adapted intervention will be called Nuevo Amanecer (A New Dawn).

Interventions

* Work with a trained counselor who is a breast cancer survivor * Meet 8 times in-person over the 8 week program with the counselor * Counselor helps participant develop a personalized support program to help her improve her quality of life * Receives information on breast cancer, its treatments, and stress management

Sponsors

California Breast Cancer Research Program
CollaboratorOTHER
Circulo de Vida Cancer Support and Resource Center
CollaboratorOTHER
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Self-identifies as Latina * Diagnosed with Stage 0, I, II, or III in the prior month * Primarily Spanish-speaking, or Spanish monolingual * Aged 18 or older * Diagnosed in Alameda, Contra Costa, San Mateo, San Francisco or Santa Clara counties, California.

Exclusion criteria

* Previous cancer diagnosis except for non-melanoma skin cancer * Terminal illness * Stage IV breast cancer (distant metastasis)

Design outcomes

Primary

MeasureTime frameDescription
Total Score of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline and 6 month assessmentFACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to each of the FACT-B subscale. The total overall score is based on the sum of modified subscales (see above primary outcomes for modifications to subscales). Possible score ranges for the total overall score were 0-108. Higher scores indicated greater well-being.
Social/Family Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline and 6 month assessmentFACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: social/family well-being subscale. Of 7 items, 2 were dropped because the items were conditional on having a partner (resulting in lots of missing data). Modified subscale was scored by summing items. Possible score ranges for social/family well-being were 0-20. Higher scores indicated greater well-being.
Emotional Well-being a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline and 6 month assessmentFACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: emotional well-being subscale. Of 6 items, 1 was dropped because of low item-scale correlations and it was conceptually different from the other items on that scale (only positively worded item on the scale). Modified subscale was scored by summing items. Possible score ranges for emotional well-being were 0-20. Higher scores indicated greater well-being.
Breast Cancer Concerns a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline and 6 month assessmentFACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: breast cancer concerns subscale. Of 7 items, 2 were dropped because of low item-scale correlations and were conceptually different from the other items on that scale. Modified subscale was scored by summing items. Possible score ranges for emotional well-being were 0-28. Higher scores indicated greater well-being.
Enjoyment of Life a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline and 6 month assessmentFACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: functional well-being subscale. Of 7 items, 3 were dropped because items were conceptually different and did not converge psychometrically with the other items on that scale; the remaining 4 items were specific to enjoyment of life, thus we renamed the subscale to Enjoyment of Life. Modified subscale was scored by summing items. Possible score ranges for enjoyment of life were 0-16. Higher scores indicated greater well-being.
Physical Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline and 6 month assessmentFACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: physical well-being subscale. Of 7 items, 1 was dropped because it was conceptually different from other items on that scale. Modified subscale was scored by summing items. Possible score ranges for physical well-being were 0-24. Higher scores indicated greater well-being.

Secondary

MeasureTime frameDescription
Depression a Subscale of the Brief Symptom Inventory (BSI)Baseline and 6 month assessmentBSI was used to measure general symptoms of distress. BSI consists of 3 scale scores pertaining to general symptoms of distress (anxiety, depression, somatization). Response options were 0=not at all, 1=a little bit, 2=moderately, 3=quite a bit, and 4=extremely. Scores were the mean of nonmissing items. Possible score ranges for depression were 0-4. Higher scores indicated more distress.
Somatization a Subscale of the Brief Symptom Inventory (BSI)Baseline and 6 month assessmentBSI was used to measure general symptoms of distress. BSI consists of 3 scale scores pertaining to general symptoms of distress (anxiety, depression, somatization). Response options were 0=not at all, 1=a little bit, 2=moderately, 3=quite a bit, and 4=extremely. Scores were the mean of nonmissing items. Possible score ranges for somatization were 0-4. Higher scores indicated more distress.
Breast Cancer-Specific Distress of the Intrusive Thoughts ScaleBaseline and 6 month assessmentBreast cancer-specific distress was measured with the 7 item Intrusive Thoughts Scale (anchored to the breast cancer experience), a subscale of the revised Impact of Event Scale (RIES). Response options were 0=not at all, 1=rarely, 2=sometimes, and 3=often. Using the published scoring algorithm, items were summed after recoding responses to 0, 1, 3, and 5. Possible score ranges were 0-35. Higher scores indicate greater distress.
Anxiety a Subscale of the Brief Symptom Inventory (BSI)Baseline and 6 month assessmentBSI was used to measure general symptoms of distress. BSI consists of 3 scale scores pertaining to general symptoms of distress (anxiety, depression, somatization). Response options were 0=not at all, 1=a little bit, 2=moderately, 3=quite a bit, and 4=extremely. Scores were the mean of nonmissing items. Possible score ranges for anxiety were 0-4. Higher scores indicated more distress.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from February 2011 through November 2013 via flyers and word of mouth at clinics in five Northern California counties by community recruiters.

Participants by arm

ArmCount
Nuevo Amanecer Peer Support Program
Nuevo Amanecer is a cognitive-behavioral stress management program delivered by peers (Spanish-speaking Latinas who have had breast cancer) designed to address the first year of survivorship. Peer Support Program: * Work with a trained counselor who is a breast cancer survivor * Meet 8 times in-person over the 8 week program with the counselor * Counselor helps participant develop a personalized support program to help her improve her quality of life * Receives information on breast cancer, its treatments, stress management, and cognitive refraining.
76
Wait-list Control
Waits six months, and at the end of the six months is offered the option of participating in the peer support program.
75
Total151

Withdrawals & dropouts

PeriodReasonFG000FG001
3 Month AssessmentDeath01
3 Month AssessmentLost to Follow-up20
3 Month AssessmentRefused to complete40
6 Month AssessmentLost to Follow-up11
6 Month AssessmentRefused to complete40

Baseline characteristics

CharacteristicNuevo Amanecer Peer Support ProgramTotalWait-list Control
Adjuvant treatment
Both chemotherapy and radiation
33 participants60 participants27 participants
Adjuvant treatment
No treatment
11 participants24 participants13 participants
Adjuvant treatment
Only chemotherapy
14 participants25 participants11 participants
Adjuvant treatment
Only radiation
18 participants42 participants24 participants
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
10 Participants15 Participants5 Participants
Age, Categorical
Between 18 and 65 years
66 Participants136 Participants70 Participants
Age, Continuous50.8 years
STANDARD_DEVIATION 11.9
50.5 years
STANDARD_DEVIATION 10.9
50.2 years
STANDARD_DEVIATION 9.9
Breast cancer
Ductal Carcinoma In Situ (DCIS)
20 participants40 participants20 participants
Breast cancer
Invasive
56 participants111 participants55 participants
Educational attainment
6th grade to less than high school
15 participants27 participants12 participants
Educational attainment
High school graduate
11 participants24 participants13 participants
Educational attainment
Less than 6th grade
50 participants100 participants50 participants
Ethnicity (NIH/OMB)
Hispanic or Latino
76 Participants151 Participants75 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Health insurance
Any private
11 participants21 participants10 participants
Health insurance
Missing data
0 participants7 participants7 participants
Health insurance
None
3 participants5 participants2 participants
Health insurance
Public insurance only
62 participants118 participants56 participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
76 Participants151 Participants75 Participants
Region of Enrollment
United States
76 participants151 participants75 participants
Sex: Female, Male
Female
76 Participants151 Participants75 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Stage
0 (in situ)
20 participants40 participants20 participants
Stage
I (1)
12 participants23 participants11 participants
Stage
II (2)
31 participants57 participants26 participants
Stage
III (3)
13 participants31 participants18 participants
Surgery
Breast conserving
43 participants84 participants41 participants
Surgery
Mastectomy
33 participants67 participants34 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 760 / 75
serious
Total, serious adverse events
0 / 760 / 75

Outcome results

Primary

Breast Cancer Concerns a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)

FACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: breast cancer concerns subscale. Of 7 items, 2 were dropped because of low item-scale correlations and were conceptually different from the other items on that scale. Modified subscale was scored by summing items. Possible score ranges for emotional well-being were 0-28. Higher scores indicated greater well-being.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramBreast Cancer Concerns a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline16.52 units on a scaleStandard Deviation 5.43
Nuevo Amanecer Peer Support ProgramBreast Cancer Concerns a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month21.31 units on a scaleStandard Deviation 3.83
Wait-list ControlBreast Cancer Concerns a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline17.33 units on a scaleStandard Deviation 5.08
Wait-list ControlBreast Cancer Concerns a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month19.92 units on a scaleStandard Deviation 5.22
p-value: 0.013Mixed Models Analysis
Primary

Emotional Well-being a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)

FACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: emotional well-being subscale. Of 6 items, 1 was dropped because of low item-scale correlations and it was conceptually different from the other items on that scale (only positively worded item on the scale). Modified subscale was scored by summing items. Possible score ranges for emotional well-being were 0-20. Higher scores indicated greater well-being.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramEmotional Well-being a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline12.07 units on a scaleStandard Deviation 4.91
Nuevo Amanecer Peer Support ProgramEmotional Well-being a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month16.39 units on a scaleStandard Deviation 3.3
Wait-list ControlEmotional Well-being a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline12.86 units on a scaleStandard Deviation 5.14
Wait-list ControlEmotional Well-being a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month14.89 units on a scaleStandard Deviation 3.95
p-value: 0.004Mixed Models Analysis
Primary

Enjoyment of Life a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)

FACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: functional well-being subscale. Of 7 items, 3 were dropped because items were conceptually different and did not converge psychometrically with the other items on that scale; the remaining 4 items were specific to enjoyment of life, thus we renamed the subscale to Enjoyment of Life. Modified subscale was scored by summing items. Possible score ranges for enjoyment of life were 0-16. Higher scores indicated greater well-being.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramEnjoyment of Life a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline8.92 units on a scaleStandard Deviation 3.8
Nuevo Amanecer Peer Support ProgramEnjoyment of Life a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month9.79 units on a scaleStandard Deviation 3.39
Wait-list ControlEnjoyment of Life a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline9.22 units on a scaleStandard Deviation 3.43
Wait-list ControlEnjoyment of Life a Subscale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month9.30 units on a scaleStandard Deviation 3.06
p-value: 0.267Mixed Models Analysis
Primary

Physical Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)

FACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: physical well-being subscale. Of 7 items, 1 was dropped because it was conceptually different from other items on that scale. Modified subscale was scored by summing items. Possible score ranges for physical well-being were 0-24. Higher scores indicated greater well-being.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramPhysical Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline15.29 units on a scaleStandard Deviation 5.78
Nuevo Amanecer Peer Support ProgramPhysical Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month19.44 units on a scaleStandard Deviation 4.26
Wait-list ControlPhysical Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline16.76 units on a scaleStandard Deviation 5.02
Wait-list ControlPhysical Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month18.44 units on a scaleStandard Deviation 4.58
p-value: 0.015Mixed Models Analysis
Primary

Social/Family Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)

FACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: social/family well-being subscale. Of 7 items, 2 were dropped because the items were conditional on having a partner (resulting in lots of missing data). Modified subscale was scored by summing items. Possible score ranges for social/family well-being were 0-20. Higher scores indicated greater well-being.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramSocial/Family Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline13.67 units on a scaleStandard Deviation 4.42
Nuevo Amanecer Peer Support ProgramSocial/Family Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month13.72 units on a scaleStandard Deviation 4.81
Wait-list ControlSocial/Family Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline12.66 units on a scaleStandard Deviation 4.25
Wait-list ControlSocial/Family Well-being a Subcale of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month14.47 units on a scaleStandard Deviation 3.81
p-value: 0.025Mixed Models Analysis
Primary

Total Score of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)

FACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to each of the FACT-B subscale. The total overall score is based on the sum of modified subscales (see above primary outcomes for modifications to subscales). Possible score ranges for the total overall score were 0-108. Higher scores indicated greater well-being.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramTotal Score of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline66.46 units on a scaleStandard Deviation 16.92
Nuevo Amanecer Peer Support ProgramTotal Score of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month80.64 units on a scaleStandard Deviation 13.64
Wait-list ControlTotal Score of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)Baseline68.83 units on a scaleStandard Deviation 15.33
Wait-list ControlTotal Score of the Functional Assessment of Cancer Therapy-Breast Quality of Life Instrument (FACT-B)6 month77.02 units on a scaleStandard Deviation 15.62
p-value: 0.03Mixed Models Analysis
Secondary

Anxiety a Subscale of the Brief Symptom Inventory (BSI)

BSI was used to measure general symptoms of distress. BSI consists of 3 scale scores pertaining to general symptoms of distress (anxiety, depression, somatization). Response options were 0=not at all, 1=a little bit, 2=moderately, 3=quite a bit, and 4=extremely. Scores were the mean of nonmissing items. Possible score ranges for anxiety were 0-4. Higher scores indicated more distress.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramAnxiety a Subscale of the Brief Symptom Inventory (BSI)Baseline0.93 units on a scaleStandard Deviation 0.84
Nuevo Amanecer Peer Support ProgramAnxiety a Subscale of the Brief Symptom Inventory (BSI)6 month0.39 units on a scaleStandard Deviation 0.53
Wait-list ControlAnxiety a Subscale of the Brief Symptom Inventory (BSI)Baseline1.01 units on a scaleStandard Deviation 0.88
Wait-list ControlAnxiety a Subscale of the Brief Symptom Inventory (BSI)6 month0.58 units on a scaleStandard Deviation 0.76
p-value: 0.465Mixed Models Analysis
Secondary

Breast Cancer-Specific Distress of the Intrusive Thoughts Scale

Breast cancer-specific distress was measured with the 7 item Intrusive Thoughts Scale (anchored to the breast cancer experience), a subscale of the revised Impact of Event Scale (RIES). Response options were 0=not at all, 1=rarely, 2=sometimes, and 3=often. Using the published scoring algorithm, items were summed after recoding responses to 0, 1, 3, and 5. Possible score ranges were 0-35. Higher scores indicate greater distress.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramBreast Cancer-Specific Distress of the Intrusive Thoughts ScaleBaseline7.96 units on a scaleStandard Deviation 8.46
Nuevo Amanecer Peer Support ProgramBreast Cancer-Specific Distress of the Intrusive Thoughts Scale6 month3.87 units on a scaleStandard Deviation 5.79
Wait-list ControlBreast Cancer-Specific Distress of the Intrusive Thoughts ScaleBaseline8.65 units on a scaleStandard Deviation 8.91
Wait-list ControlBreast Cancer-Specific Distress of the Intrusive Thoughts Scale6 month6.27 units on a scaleStandard Deviation 8.42
p-value: 0.226Mixed Models Analysis
Secondary

Depression a Subscale of the Brief Symptom Inventory (BSI)

BSI was used to measure general symptoms of distress. BSI consists of 3 scale scores pertaining to general symptoms of distress (anxiety, depression, somatization). Response options were 0=not at all, 1=a little bit, 2=moderately, 3=quite a bit, and 4=extremely. Scores were the mean of nonmissing items. Possible score ranges for depression were 0-4. Higher scores indicated more distress.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramDepression a Subscale of the Brief Symptom Inventory (BSI)6 month0.38 units on a scaleStandard Deviation 0.48
Nuevo Amanecer Peer Support ProgramDepression a Subscale of the Brief Symptom Inventory (BSI)Baseline0.93 units on a scaleStandard Deviation 0.84
Wait-list ControlDepression a Subscale of the Brief Symptom Inventory (BSI)Baseline0.75 units on a scaleStandard Deviation 0.76
Wait-list ControlDepression a Subscale of the Brief Symptom Inventory (BSI)6 month0.46 units on a scaleStandard Deviation 0.62
p-value: 0.045Mixed Models Analysis
Secondary

Somatization a Subscale of the Brief Symptom Inventory (BSI)

BSI was used to measure general symptoms of distress. BSI consists of 3 scale scores pertaining to general symptoms of distress (anxiety, depression, somatization). Response options were 0=not at all, 1=a little bit, 2=moderately, 3=quite a bit, and 4=extremely. Scores were the mean of nonmissing items. Possible score ranges for somatization were 0-4. Higher scores indicated more distress.

Time frame: Baseline and 6 month assessment

Population: Using intention-to-treat analyses, used repeated-measures linear regression models to estimate the intervention effects on outcomes. Likelihood-based model estimation assumed outcome responses were missing at random.

ArmMeasureGroupValue (MEAN)Dispersion
Nuevo Amanecer Peer Support ProgramSomatization a Subscale of the Brief Symptom Inventory (BSI)Baseline0.93 units on a scaleStandard Deviation 0.78
Nuevo Amanecer Peer Support ProgramSomatization a Subscale of the Brief Symptom Inventory (BSI)6 month0.52 units on a scaleStandard Deviation 0.51
Wait-list ControlSomatization a Subscale of the Brief Symptom Inventory (BSI)Baseline0.75 units on a scaleStandard Deviation 0.59
Wait-list ControlSomatization a Subscale of the Brief Symptom Inventory (BSI)6 month0.66 units on a scaleStandard Deviation 0.6
p-value: 0.005Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026